






Gud Knight
























































Skip to content






 





About 

Overview
Management Team
Board of Directors
Community


Products
Partnering
Investors 

Overview
Press Releases
Events & Webcasts
Financial Reports
Presentations & Fact Sheets
Product Pipeline
Shareholder Information
Governance
In the News
E-mail Alerts


Careers
Contact Us
Français
 




Site Search



Search for:

Search
 























Building Canada’s leading
specialty pharma company





Press Releases











VIEW MORE





Products




BIJUVA™IMVEXXY™IBSRELA®TRELSTAR® ProstateTRELSTAR® EndometriosisIluvienNerlynxNerlynx Patient ChecklistNerlynx Prescriber ChecklistBurinex





Stock Info





Ticker: GUD.TO
Exchange: TSX (C$)
Price: 
Change: 
Volume: 
Updated: 






VIEW MORE





















 © 2021 All rights reserved | Knight Therapeutics Inc.

 






Legal Notices
Privacy
 





















